|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9398
|
|
pubmed:dateCreated |
2003-12-5
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
29
|
|
pubmed:volume |
362
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1854; discussion 1856
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14654328-Dose-Response Relationship, Drug,
pubmed-meshheading:14654328-Drug Administration Schedule,
pubmed-meshheading:14654328-Drug Approval,
pubmed-meshheading:14654328-Fluorobenzenes,
pubmed-meshheading:14654328-Humans,
pubmed-meshheading:14654328-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:14654328-Hypertension,
pubmed-meshheading:14654328-Pyrimidines,
pubmed-meshheading:14654328-Sulfonamides,
pubmed-meshheading:14654328-United States
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The stain wars.
|
|
pubmed:publicationType |
Letter,
Comment
|
